Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer’s Kindler Said to Leave After Jilting Read
Bloomberg
Tuesday, December 7, 2010 - 7:55am
tags:
Ian Read, Jeff Kindler, Pharma CEOs, Pfizer
Why the Street Should Love King Pharmaceuticals' Earnings
Motley Fool
Monday, December 6, 2010 - 7:30pm
tags:
earnings, King, Teva Pharmaceuticals, Endo, Elan
Spectrum's Zevalin shows positive results in study
Yahoo/AP
Monday, December 6, 2010 - 7:26pm
tags:
Zevalin, Spectrum Pharmaceuticals, follicular lymphoma
Orexigen braces for advisory panel's Contrave review
Fierce Biotech
Monday, December 6, 2010 - 5:04pm
tags:
Orexigen, Contrave, FDA, advisory panels, obesity
Read takes over a Pfizer facing many difficulties
Yahoo/AP
Monday, December 6, 2010 - 5:02pm
tags:
Pfizer, Jeff Kindler, Ian Read
Abbott Labs, The Stent Doc And A Pig Roast
Pharmalot
Monday, December 6, 2010 - 4:24pm
tags:
Abbott Laboratories, stents, physicians
Will Impax Laboratories Earn or Burn?
Motley Fool
Monday, December 6, 2010 - 4:21pm
tags:
Impax, Teva Pharmaceuticals, Pfizer, Elan
Pfizer Change of Guard Won't Make a Difference
Seeking Alpha
Monday, December 6, 2010 - 11:34am
tags:
Pfizer, Pharma CEOs, Ian Read, Jeff Kindler
Otsuka Sets Price for $2.4 Billion Tokyo IPO at the Lower End of Its Range
Bloomberg
Monday, December 6, 2010 - 11:30am
tags:
Otsuka, Japan, IPOs
Novartis: Tasigna surpasses Glivec in study
Fierce Pharma
Monday, December 6, 2010 - 11:23am
tags:
Tasigna, Glivec, Novartis, leukemia
Watson CEO Must Answer FTC Subpoena
Pharmalot
Monday, December 6, 2010 - 11:22am
tags:
Watson Pharmaceuticals, Pharma CEOs, FTC, pay-for-delay, Paul Bisaro
Celgene: Revlimid Cancer Risk Knocks Stock
TheStreet.com
Monday, December 6, 2010 - 11:04am
tags:
Celgene, Revlimid, Multiple Myeloma
Onyx Drug’s Mild Side Effects Let Myeloma Patients Stay on It
Bloomberg
Monday, December 6, 2010 - 11:02am
tags:
myeloma, ONYX Pharmaceuticals, Carfilzomib
Genentech: positive results from cancer drug study
Yahoo/AP
Monday, December 6, 2010 - 11:00am
tags:
Genentech, Rituxan, Roche, Biogen Idec, non-Hodgkin's lymphoma
Dividend Increases Expected for Abbott Laboratories
Seeking Alpha
Monday, December 6, 2010 - 10:57am
tags:
dividends, Abbott Laboratories
Elan names Robert Ingram chairman
Marketwatch
Monday, December 6, 2010 - 10:56am
tags:
Robert Ingram, Elan
Biographical information on new Pfizer CEO Ian Read
Yahoo/AP
Monday, December 6, 2010 - 10:55am
tags:
Ian Read, Pfizer, Jeff Kindler, Pharma CEOs
Pfizer CEO Kindler Steps Down Unexpectedly
TheStreet.com
Sunday, December 5, 2010 - 10:18pm
tags:
Pfizer, Jeff Kindler, Pharma CEOs
Synta's Lead Program Gains Momentum
Seeking Alpha
Sunday, December 5, 2010 - 12:28pm
tags:
Synta, mTOR inhibitors, STA-9090, cancer
New Approach to Research by Pharmaceutical Company (Pfizer)
Sciblogs
Sunday, December 5, 2010 - 12:26pm
tags:
Pfizer, R&D

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.